year
increas
childbear
year
decreas
advanc
age
although
increas
may
seen
elderli
term
restrict
activ
prompt
visit
physician
greatest
number
ill
associ
rhinovirus
follow
influenza
virus
howev
compar
rhinoviru
influenza
doubt
influenza
virus
produc
sever
symptom
year
major
influenza
outbreak
may
even
identifi
greater
frequenc
moreov
unlik
virus
sever
influenza
infect
high
age
especi
older
individu
influenza
vaccin
avail
half
centuri
prove
effect
prevent
hospit
pneumonia
influenza
outbreak
influenza
type
b
antivir
agent
amantadin
rimantadin
provid
approxim
equival
signillc
efficaci
protect
clinic
ill
result
influenza
type
howev
potenti
side
effect
mark
amantadin
studi
shown
rate
treatment
withdraw
greater
rimantadin
placebo
enter
next
centuri
may
well
see
improv
influenza
vaccin
well
advent
antivir
agent
effect
type
type
b
influenza
children
month
old
rel
spare
communitybas
respiratori
infect
annual
frequenc
respiratori
ill
rise
second
year
life
fall
figur
frequenc
increas
childbear
year
parent
expos
children
age
group
greatest
burden
respiratori
ill
apart
mere
presenc
children
famili
age
oldest
child
correl
occurr
ill
figur
pattern
reflect
import
role
children
introduct
transmiss
ill
adult
advanc
age
frequenc
respiratori
ill
decreas
although
sever
seri
shown
increas
among
individu
late
figur
tabl
summar
etiolog
agent
greatest
concern
regard
respiratori
ill
commun
lower
respiratori
ill
communitybas
studi
difficult
identifi
base
clinic
characterist
altern
indic
sever
must
use
group
use
activ
restrict
number
physician
consult
data
frequenc
ill
day
work
report
telephon
interview
measur
rang
diseas
burden
shown
scale
increas
sever
tabl
reinfect
agent
major
featur
nearli
virus
reinfect
may
produc
clinic
diseas
consequ
term
transmiss
ill
other
respiratori
syncyti
viru
notori
produc
bronchiol
pneumonia
young
children
also
frequent
caus
reinfect
either
asymptomat
infect
mild
respiratori
ill
older
individu
similar
pattern
evid
decemb
american
journal
medicin
volum
kuppl
parainfluenza
virus
approxim
children
lo
year
old
infect
parainfluenza
virus
type
year
indic
signific
rise
antibodi
titer
infect
asymptomat
nevertheless
consequ
term
transmiss
rhinovirus
contrast
produc
mild
ill
age
group
ill
like
asymptomat
older
individu
coronavirus
larg
overlook
nowaday
even
though
techniqu
identif
improv
pattern
ill
produc
virus
similar
rhinovirus
adenovirus
produc
specif
syndrom
initi
infect
virus
result
pneumonia
requir
hospit
great
concern
older
individu
year
estim
million
influenzarel
excess
respiratori
ill
occur
ij
popul
year
age
older
individu
estim
frequenc
million
excess
respiratori
ill
per
year
influenza
virus
greatest
potenti
produc
sever
diseas
older
individu
particularli
underli
chronic
condit
group
use
data
activ
restrict
number
physician
consult
tecumseh
michigan
examin
rel
import
virus
respons
respiratori
infect
ill
index
deriv
combin
frequenc
ill
proport
caus
medic
consult
khinovirus
rank
import
definit
virus
often
prompt
physician
consult
caus
mani
instanc
ill
influenza
even
though
much
less
common
total
infect
rate
influenza
type
b
exhibit
much
pronounc
peak
older
children
young
adult
especi
age
year
peak
older
children
young
adult
even
extrem
rel
spare
age
group
even
evid
influenza
type
h
n
anoth
import
endpoint
assess
sever
possibl
produc
asthmat
attack
young
children
although
less
notabl
consequ
commun
certainli
import
regard
need
hospit
util
healthcar
resourc
gener
studi
examin
rhinovirus
found
agent
lead
trigger
asthmat
attack
young
children
simpli
virus
common
influenza
virus
also
import
sharpli
season
contribut
depend
whether
data
obtain
period
transmiss
apart
seriou
morbid
commun
influenza
caus
excess
death
threshold
level
death
attribut
mainli
type
influenza
also
type
b
year
eg
interventton
influenza
vaccin
avail
approxim
year
vaccin
found
effect
random
control
trial
involv
young
militari
recruit
underutil
prevent
pneumoniaand
influenzarel
hospit
part
direct
demonstr
efficaci
elderli
attempt
determin
whether
vaccin
actual
prevent
hospit
pneumonia
influenza
group
conduct
observ
must
weigh
potenti
side
effect
common
amantadin
studi
southern
michigan
examin
influenza
type
b
outbreak
period
work
design
look
hospit
confirm
caus
influenza
virtu
viru
isol
rise
antibodi
titer
rather
focus
diagnosi
pneumonia
influenza
influenza
season
contrast
data
find
outsid
influenza
season
comparison
compar
communitybas
control
hospit
prevent
hospit
pneumonia
influenza
vaccin
effect
pure
outbreak
influenza
h
n
versu
season
effect
year
mark
mainli
type
b
influenza
versu
season
effect
year
mark
primarili
type
h
n
influenza
versu
effect
season
tabl
ii
anoth
studi
conduct
fedson
colleaguesl
manitoba
yield
essenti
result
extend
observ
hospit
respiratori
condit
data
confirm
vaccin
prevent
sever
complic
caus
influenza
mere
effect
younger
adult
whose
immun
system
greater
abil
respond
random
control
trial
assess
use
antivir
prophylaxi
shown
amantadin
rimantadin
approxim
equival
efficaci
depend
past
experi
popul
circul
virus
studi
conduct
michigan
show
amantadin
effect
protect
laboratoryconfirm
clinic
ill
result
influenza
type
hini
find
statist
signific
p
oool
work
vermont
found
amantadin
effect
rimantadin
effect
prevent
clinic
ill
caus
influenza
type
h
nj
type
h
n
result
highli
signific
p
oool
l
studi
michigan
show
individu
amantadin
group
versu
placebo
group
withdrew
treatmentlz
vermont
studi
individu
withdrew
amantadin
therapi
notabl
howev
withdraw
rate
rimantadin
group
individu
differ
placebo
group
individu
rimantidin
also
valuabl
therapi
wide
avail
outsid
unit
state
found
drug
reduc
viral
shed
caus
influenza
type
infect
use
treatment
clinic
ill
howev
use
therapi
resist
variant
recov
rimantadineor
amantadinetr
patient
resist
issu
prophylaxi
clinic
signific
shed
resist
viru
treat
individu
unclear
still
recov
quickli
without
shed
resist
variant
transmit
contact
treat
patient
associ
failur
prophylaxi
conclus
enter
next
centuri
expect
improv
influenza
vaccin
well
antivir
agent
better
abl
combat
influenza
three
question
particular
clinic
interest
involv
antivir
effect
type
b
influenza
especi
valuabl
mix
outbreak
b
way
antivir
work
pneumonia
caus
influenza
c
possibl
adrninist
treatment
first
hour
mani
patient
present
physician
may
abl
answer
question
move
era
antivir
wide
use
influenza
